Profil

Avatar

Željko Prijović

Zvanje:
Naučni saradnik
Direktni telefoni:
+381643161828
Lokal:
Naučna oblast:
1
Veće oblasti:
Hemija,
Orcid broj:
0000-0003-1069-2453
Organizaciona jedinica:
070

DIPLOME

ZVANJA

M faktor

Kategorija Broj Koeficijent Ukupno
M11 0 14 0
M12 0 10 0
M13 0 7 0
M14 0 4 0
M15 0 3 0
M16 0 2 0
M17 0 3 0
M18 0 2 0
M21a 4 10 40
M21 6 8 48
M22 6 5 30
M23 2 3 6
M24 0 2 0
M25 0 1.5 0
M26 0 1 0
M27 0 0.5 0
M28a 0 3.5 0
M28b 0 2.5 0
M29a 0 1.5 0
M29b 0 1.5 0
M29v 0 1 0
M31 0 3.5 0
M32 0 1.5 0
M33 0 1 0
M34 2 0.5 1
M35 0 0.3 0
M36 0 1.5 0
M41 0 7 0
M42 0 5 0
M43 0 3 0
M44 0 2 0
M45 0 1.5 0
M46 0 1 0
M47 0 0.5 0
M48 0 2 0
M49 0 1 0
M51 0 2 0
M52 0 1.5 0
M53 0 1 0
M54 0 0.2 0
M55 0 1 0
M56 0 0.3 0
M57 0 0.2 0
M61 0 1.5 0
M62 0 1 0
M63 0 1 0
M64 0 0.2 0
M65 0 0 0
M66 0 1 0
M67 0 0 0
M68 0 0 0
M69 0 0 0
M71 0 6 0
M72 0 3 0
M81 0 0 0
M82 0 0 0
M83 0 0 0
M84 0 0 0
M85 0 0 0
M86 0 0 0
M87 0 0 0
M91 2 0 0
M92 0 0 0
M93 0 0 0
M94 0 0 0
M95 0 0 0
M96 0 0 0
M97 0 0 0
M98 0 0 0
M99 0 0 0
M101 0 0 0
M102 0 0 0
M103 0 0 0
M104 0 0 0
M105 0 0 0
M106 0 0 0
M107 0 0 0
M108 0 0 0
M109 0 0 0
M110 0 0 0
M111 0 0 0
M112 0 0 0
M121 0 3 0
M122 0 2 0
M123 0 1 0
M124 0 1 0

Ukupno M faktor:

125
--> -->--> -->--> --> --> -->--> -->--> --> -->-->

NI radovi

# Naziv, Datum, Grupa, Vrsta Godina Autori Status Akcija
1 BQC-G, a tumor-selective anti-cancer prodrug
US Patent Office , USA , 2016
M90 | M91 		2016 Zeljko M. Prijovic, Yu-Lin Leu and Steve Roffler
Odobren
2 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
US Patent office , USA , 2013
M90 | M91 		2013 Steve Roffler, Chia-Hung Wu, Wolfgang Schechinger, Kai-Chuan Chen, Zeljko M. Prijovic
Odobren
3 Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation
Molecular Pharmaceutics , , 2016
M20 | M21 		2016 Zeljko M. Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, Ping-Ting Huang, Kai-Chuan Chen, Tian-Lu Cheng, Yu-Lin Leu, Steve R. Roffler
Odobren
4 Mast cells mediate malignant pleural effusion formation
Journal of Clinical Investigation , , 2015
M20 | M21a 		2015 Anastasios D. Giannou, Antonia Marazioti, Magda Spella, Nikolaos I. Kanellakis, Hara Apostolopoulou, Ioannis Psallidas, Zeljko M. Prijovich, Malamati Vreka, Dimitra E. Zazara, Ioannis Lilis, Vassilios Papaleonidopoulos, Chrysoula A. Kairi, Alexandra L. Patmanidi, Ioanna Giopanou, Nikolitsa Spiropoulou, Vaggelis Harokopos, Vassilis Aidinis, Dionisios Spyratos, Stamatia Teliousi, Helen Papadaki, Stavros Taraviras, Linda A. Snyder, Oliver Eickelberg, Dimitrios Kardamakis, Yoichiro Iwakura, Thorsten B. Feyerabend, Hans-Reimer Rodewald, Ioannis Kalomenidis, Timothy S. Blackwell, Theodora Agalioti, Georgios T. Stathopoulos
Odobren
5 Versatile online SPE-HPLC method for the analysis of Irinotecan and its clinically relevant metabolites in biomaterials
Journal of Separation Science , , 2014
M20 | M23 		2014 Zeljko M. Prijovich, Pierre-Alain Burnouf, Steve R. Roffler
Odobren
6 The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif
PLoS ONE , , 2013
M20 | M21 		2013 Yi-Chieh Lin, Bing-Mae Chen, Wei-Cheng Lu, Chien-I Su, Zeljko M. Prijovich, Wen-Chuan Chung, Pei-Yu Wu, Kai-Chuan Chen, I-Chiao Lee, Ting-Yi Juan, Steve R. Roffler
Odobren
7 ECSTASY, an adjustable membrane-tethered/soluble protein expression system for the directed evolution of mammalian proteins
Protein Engineering Design and Selection , , 2012
M20 | M22 		2012 C.-P. Chen, Y.-T. Hsieh, Z. M. Prijovich, H.-Y. Chuang, K.-C. Chen, W.-C. Lu, Q. Tseng, Y.-L. Leu, T.-L. Cheng, S. R. Roffler
Odobren
8 A Humanized Immunoenzyme with Enhanced Activity for Glucuronide Prodrug Activation in the Tumor Microenvironment
Bioconjugate Chemistry , , 2011
M20 | M22 		2011 Kai-Chuan Chen, Shih-Yen Wu, Yu-Lin Leu, Zeljko M. Prijovich, Bing-Mae Chen, Hsin-Ell Wang, Tian-Lu Cheng, Steve R. Roffler
Za izmenu
9 Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β–glucuronidase in tumors
Cancer Gene Therapy , , 2011
M20 | M22 		2011 P-T Huang, K-C Chen, Z M Prijovich, T-L Cheng, Y-L Leu, S R Roffler
Odobren
10 Antiangiogenesis Targeting Tumor Microenvironment Synergizes Glucuronide Prodrug Antitumor Activity
Clinical Cancer Research , , 2009
M20 | M21a 		2009 Ting-Yi Juan, Steve R. Roffler, Hsien-San Hou, Shih-Ming Huang, Kai-Chuan Chen, Yu-Lin Leu, Zeljko M. Prijovich, Cheng-Ping Yu, Chang-Chieh Wu, Guang-Huan Sun, Tai-Lung Cha
Odobren
11 Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy
Molecular Cancer Therapeutics , , 2009
M20 | M22 		2009 Zeljko M. Prijovich, Kai-Chuan Chen, Steve R. Roffler
Odobren
12 Directed Evolution of a Lysosomal Enzyme with Enhanced Activity at Neutral pH by Mammalian Cell-Surface Display
Chemistry & Biology , , 2008
M20 | M22 		2008 Kai-Chuan Chen, Chia-Hung Wu, Chuan-Yuan Chang, Wei-Cheng Lu, Qingzong Tseng, Zeljko M. Prijovich, Wolfgang Schechinger, Yen-Chywan Liaw, Yu-Lin Leu, Steve R. Roffler
Za izmenu
13 Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin
Cancer Chemotherapy and Pharmacology , , 2006
M20 | M22 		2006 Zeljko M. Prijovich, Yu-Lin Leu, Steve R. Roffler
Odobren
14 Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes
Cancer Gene Therapy , , 2006
M20 | M23 		2006 K-C Chen, T-L Cheng, Y-L Leu, Z M Prijovich, C-H Chuang, B-M Chen, S R Roffler
Odobren

Citati

Broj citata Referenca Status
Link | Dokument
Za izmenu